http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101054951-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6837 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate | 2009-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2011-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2011-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101054951-B1 |
titleOfInvention | CAPN12, a molecule for diagnosing and treating liver cancer, and a kit comprising the same |
abstract | The present invention provides a marker detecting composition for diagnosing and treating liver cancer, including a preparation for measuring the expression level of CAPN12 (calpain 12), a kit comprising the composition, a microarray for diagnosing liver cancer using the marker, and It relates to a method for detecting the marker. According to the present invention, the marker may be utilized for early diagnosis of liver cancer to quickly determine the time of surgery or medication for liver cancer patients, and thus, may significantly contribute to improving survival.n n n n Liver Cancer, Marker, Microarray, Diagnostics, Kit |
priorityDate | 2009-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 465.